Editorial Board — Medscape Gastroenterology

Chair/Journal Editor

  • Geoffrey Braden, MD
    • Drexel University College of Medicine
      Aria Health Hospital System
      Philadelphia, Pennsylvania
 

Board Members

 

Chair/Journal Editor Details

Geoffrey Braden, MD
Geoffrey Braden, MD

Associate Clinical Professor of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania; Chief, Division of Internal Medicine, Aria Hospital System, Philadelphia, Pennsylvania

Geoffrey Braden, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Janssen Biotech; AbbVie; Allergan
Serve(d) as a speaker or member of a speakers bureau for: Janssen Biotech; AbbVie; Allergan
Received income in an amount equal to or greater than $250 from: Janssen Biotech; AbbVie; Allergan

 

Board Member Details

David L. Carr-Locke, MD
David L. Carr-Locke, MD

Professor of Medicine, Icahn School of Medicine at Mount Sinai; Chief, Division of Digestive Diseases, Mount Sinai Beth Israel Medical Center, New York, New York

David L. Carr-Locke, MD, has disclosed the following relevant financial relationships:
Serve(d) as a sidrector, officer, partner, employee, advisor, consultant, or trustee for: Boston Scientific Edoscopy; Cook Medical; EndoChoice
Received income in an amount equal to or greater than $250 from: US Endoscopy; Telemed Systems

Stephen Hanauer, MD
Stephen Hanauer, MD

Professor of Medicine, Medical Director, Digestive Health Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Stephen B. Hanauer, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AbbVie; Actavis Group hf; Amgen Inc; Arena Pharmaceuticals, Inc.; Astellas Pharma Global; AstraZeneca Pharmaceuticals LP; Baxter; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Catabasis; Celgene; Celltrion; Cellceutix; Cubist Pharmaceuticals; Ferring Pharmaceuticals; Forest Laboratories, Inc.; Genentech BioOncology; Glenmark; GlaxoSmithKline; Hospira, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Eli Lilly and Company; Luitpold Pharmaceuticals; Meda Pharmaceuticals, Inc; Merck & Co; Nestle; Novartis Pharmaceuticals Corporation; Novo Nordisk; Pfizer, Inc; Prometheus Laboratories Inc.; Receptos; Salix Pharmaceuticals, Inc.; sanofi-aventis; Seattle Genetics Inc.; Seres Health; Shire; Sun Pharmaceuticals; Takeda Pharmaceuticals North America, Inc.; Theradiag; TiGenix; UCB Pharma, Inc.; VHsquared
Serve(d) as a speaker or member of a speakers bureau for: AbbVie; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc
Institution received research grant from: AbbVie; Amgen Inc; Celgene; Genentech BioOncology; GlaxoSmithKline; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Eli Lilly and Company; Luitpold Pharmaceuticals; Novartis Pharmaceuticals Corporation; Novo Nordisk; Pfizer, Inc; Prometheus Laboratories Inc.; Receptos; sanofi-aventis; Takeda Pharmaceuticals North America, Inc.; UCB Pharma, Inc.
Data and Safety Monitoring Board: Bristol-Myers Squibb Company

David A. Johnson, MD
David A. Johnson, MD

Professor of Medicine, Chief of Gastroenterology, Eastern Virginia Medical School, Norfolk, Virginia

David A. Johnson, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for:
Pfizer Inc; Epigenomics; WebMD; CRH Medical; Medtronic
Received income in an amount equal to or greater than $250 from:
Pfizer Inc; Epigenomics; WebMD; CRH Medical; Medtronic

Philip O. Katz, MD
Philip O. Katz, MD

Clinical Professor of Medicine, The Sidney Kimmel Medical College at Thomas Jefferson University; Chairman, Division of Gastroenterology, Einstein Medical Center Philadelphia, Philadelphia, Pennsylvania

Phillip O. Katz, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Pfizer Inc.; Torax Medical

Brian E. Lacy, MD, PhD
Brian E. Lacy, MD, PhD

Professor and Section Chief, Gastroenterology and Hepatology, Department of Medicine; Director, GI Motility Laboratory, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Brian E. Lacy, MD, PhD, has disclosed the following relevant financial relationships:
Member of scientific advisory boards for: Ironwood Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.
Received a research grant from: National Institutes of Health
Scientific Advisory Board, yearly meetings: Salix Pharmaceuticals, Inc.; Forest Laboratories, Inc.; Ironwood Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.

Bret A. Lashner, MD
Bret A. Lashner, MD

Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio

Bret A. Lashner, MD, has disclosed no relevant financial relationships.

Paul Martin, MD
Paul Martin, MD

Professor of Medicine; Chief, Division of Hepatology, University of Miami School of Medicine and Hospital, Miami, Florida

Paul Martin, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Gilead Sciences, Inc.; Merck & Co., Inc.; Bristol-Myers Squibb Company; AbbVie
Serve(d) as a speaker or a member of a speakers bureau for: Gilead Sciences, Inc.; Merck & Co.; Bristol-Myers Squibb Company; AbbVie Received income in an amount equal to or greater than $250 from: Gilead Sciences, Inc; Bristol-Myers Squibb Company

Valerio Nobili, MD
Valerio Nobili, MD

Chief of Department, Hepatometabolic Unit, Bambino Gesù Children's Hospital, Rome, Italy

Valerio Nobili, MD, has disclosed no relevant financial relationships.

Brant Oelschlager, MD
Brant Oelschlager, MD

Professor and Vice Chair, Department of Surgery, University of Washington; Director, Center for Esophageal and Gastric Surgery, University of Washington Medical Center, Seattle, Washington

Brant Oelschlager, MD, has disclosed the following relevant financial relationships:
Received a research grant from: Torax Medical; Endogastric Solutions
Received income in an amount equal to or greater than $250 from: Endogastric Solutions

Douglas K. Rex, MD
Douglas Rex, MD

Douglas K. Rex, MD, Distinguished Professor of Medicine, Indiana University; Director of Endoscopy, Indiana University Hospital, Indianapolis, Indiana

Douglas K. Rex, MD, has disclosed the following relevant financial relationships:
Served on scientific advisory boards for: Colonary Solutions
Served(d) as a consultant for: Boston Scientific; Ironwood Pharmaceuticlas; Novo Nordisk; Olympus
Received research support from: Boston Scientific; Covidien; EndoAid, Ltd; Endochoice; Olympus; Paion AG

Nancy S. Reau, MD
Nancy S. Reau, MD

Associate Professor of Medicine; Chief, Section of Hepatology; Associate Director, Solid Organ Transplant, Rush University Medical Center, Chicago, Illinois

Nancy S. Reau, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AbbVie; Gilead Sciences, Inc.; Merck & Co Inc.; Intercept Pharmaceuticals, Inc.; Bristol-Myers Squibb Company,
Received research grant from: AbbVie; Gilead Sciences, Inc.; Intercept Pharmaceuticals, Inc.